Pfizer and BioNTech SE were granted fast track designation by the FDE for two of the companies’ four vaccine candidates against the coronavirus. Pfizer shares added 2%. BioNTech added 5%. CNBC's Joe Kernen breaks down the news and what it means for the market. Subscribe to CNBC PRO for access to investor and analyst insights and more: [ Ссылка ]
» Subscribe to CNBC TV: [ Ссылка ]
» Subscribe to CNBC: [ Ссылка ]
» Subscribe to CNBC Classic: [ Ссылка ]
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: [ Ссылка ]
Follow CNBC on LinkedIn: [ Ссылка ]
Follow CNBC News on Facebook: [ Ссылка ]
Follow CNBC News on Twitter: [ Ссылка ]
Follow CNBC News on Instagram: [ Ссылка ]
#CNBC
#CNBCTV
